Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis

International Journal of Cardiology

Volumn 189, Issue 1, 2015, Pages 1-5

  Nagao, Satomi ^a   Watanabe, Hiroshi ^a   Sobue, Yoshihiro ^b   Kodama, Makoto ^a   Tanaka, Junichi ^c   Tanabe, Naohito ^d   Suzuki, Eiichi ^c   Narita, Ichiei ^c   Watanabe, Eiichi ^b   Aizawa, Yoshifusa ^a   Minamino, Tohru ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^d UNIVERSITY OF NIIGATA PREFECTURE   (Japan)

Author keywords

Arrhythmia; Electrocardiography; Heart failure; Risk factors; Sarcoidosis

Indexed keywords

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; EXTRACARDIAC SARCOIDOSIS; FEMALE; FOLLOW UP; HEART DISEASE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PR INTERVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRS INTERVAL; RISK ASSESSMENT; RISK FACTOR; SARCOIDOSIS; ST SEGMENT; SYSTOLIC DYSFUNCTION; T WAVE; ARRHYTHMIAS, CARDIAC; COMPLICATION; CONFIDENCE INTERVAL; CONGENITAL MALFORMATION; HEART MUSCLE CONDUCTION SYSTEM; INCIDENCE; KAPLAN MEIER METHOD; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; ATRIOVENTRICULAR BLOCK; CONFIDENCE INTERVALS; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84929165783     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.175     Document Type: Article

References (26)

1. K. Iwai, T. Tachibana, T. Takemura, Y. Matsui, M. Kitaichi, Y. Kawabata, Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan, Acta Pathol. Jpn. 43 (1993) 372-376.
2. G.W. Hunninghake, U. Costabel, M. Ando, R. Baughman, J.F. Cordier, R. du Bois, et al., ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders, Sarcoidosis Vasc. Diffuse Lung Dis. 16 (1999) 149-173.
3. R.P. Baughman, A.S. Teirstein, M.A. Judson, M.D. Rossman, H. Yeager Jr., E.A. Bresnitz, et al., Clinical characteristics of patients in a case control study of sarcoidosis, Am. J. Respir. Crit. Care Med. 164 (2001) 1885-1889.
4. K.J. Silverman, G.M. Hutchins, B.H. Bulkley, Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis, Circulation 58 (1978) 1204-1211.
5. W.C. Roberts, H.A. McAllister Jr., V.J. Ferrans, Sarcoidosis of the heart. A clinicopath-ologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11), Am. J. Med. 63 (1977) 86-108.
6. C.Z. Chiu, S. Nakatani, G. Zhang, T. Tachibana, F. Ohmori, M. Yamagishi, et al., Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis, Am. J. Cardiol. 95 (2005) 143-146.
7. T. Ise, T. Hasegawa, Y. Morita, N. Yamada, A. Funada, H. Takahama, et al., Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis, Heart 100 (2014) 1165-1172.
8. K. Yodogawa, Y. Seino, T. Ohara, H. Takayama, T. Katoh, K. Mizuno, Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis, Ann. Noninvasive Electrocardiol. 16 (2011) 140-147.
9. Y. Kato, S. Morimoto, A. Uemura, S. Hiramitsu, T. Ito, H. Hishida, Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block, Sarcoidosis Vasc. Diffuse Lung Dis. 20 (2003) 133-137.
10. K. Yodogawa, Y. Seino, R. Shiomura, K. Takahashi, I. Tsuboi, S. Uetake, et al., Recovery of atrioventricular block following steroid therapy inpatients with cardiac sarcoidosis, J. Cardiol. 62 (2013) 320-325.
11. T. Shimada, K. Shimada, T. Sakane, K. Ochiai, H. Tsukihashi, M. Fukui, et al., Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging, Am. J. Med. 110 (2001) 520-527.
12. H. Yamagishi, N. Shirai, M. Takagi, M. Yoshiyama, K. Akioka, K. Takeuchi, et al., Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET, J. Nucl. Med. 44 (2003) 1030-1036.
13. N.Y. Hamzeh, F.S. Wamboldt, H.D. Weinberger, Management of cardiac sarcoidosis in the United States: a Delphi study, Chest 141 (2012) 154-162.
14. E. Stein, I. Jackler, B. Stimmel, W. Stein, L.E. Siltzbach, Asymptomatic electrocardio-graphic alterations in sarcoidosis, Am. Heart J. 86 (1973) 474-477.
15. E.H. Schuster, G. Conrad, F. Morris, M.L. Fisher, N.H. Carliner, G.D. Plotnick, et al., Systemic sarcoidosis and electrocardiographic conduction abnormalities. Electro-physiologic evaluation of two patients, Chest 78 (1980) 601-604.
16. M. Thunell, P. Bjerle, N. Stjernberg, ECG abnormalities in patients with sarcoidosis, Acta Med. Scand. 213 (1983) 115-118.
17. Diagnostic standard and guidelines for sarcoidosis, Jpn. J. Sarcoidosis Granulomatous Disord. 27 (2007) 89-102.
18. M.K. Das, B. Khan, S. Jacob, A. Kumar, J. Mahenthiran, Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease, Circulation 113 (2006) 2495-2501.
19. J.L. Schuller, M.D. Olson, M.M. Zipse, P.M. Schneider, R.G. Aleong, H.D. Wienberger, et al, Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement, J. Cardiovasc. Electrophysiol. 22 (2011) 1243-1248.
20. A.A. El-Menyar, S.M. Abdou, Impact of left bundle branch block and activation pattern on the heart, Expert. Rev. Cardiovasc. Ther. 6 (2008) 843-857.
21. H. Watanabe, N. Makita, N. Tanabe, T. Watanabe, Y. Aizawa, Electrocardiographic abnormalities and risk of complete atrioventricular block, Int. J. Cardiol. 155(3) (2012 Mar 22) 462-464.
22. M. Homsi, L. Alsayed, B. Safadi, J. Mahenthiran, M.K. Das, Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging, Ann. Noninvasive Electrocardiol. 14 (2009) 319-326.
23. M.K. Das, C. Saha, H. El Masry, J. Peng, G. Dandamudi, J. Mahenthiran, et al., Fragmented QRS on a 12-lead ECG: a predictor of mortality and cardiac events in patients with coronary artery disease, Heart Rhythm. 4 (2007) 1385-1392.
24. K. Maehara, T. Kokubun, N. Awano, K. Taira, M. Ono, T. Furukawa, et al., Detection of abnormal high-frequency componentsinthe QRS complexbythe wavelet transform in patients with idiopathic dilated cardiomyopathy, Jpn. Circ. J. 63 (1999) 25-32.
25. H. Morita, K.F. Kusano, D. Miura, S. Nagase, K. Nakamura, S.T. Morita, et al, Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome, Circulation 118 (2008) 1697-1704.
26. D.H. Birnie, W.H. Sauer, F. Bogun, J.M. Cooper, D.A. Culver, C.S. Duvernoy, et al, HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis, Heart Rhythm. 11 (2014) 1305-1323.